[{"_id":"551f89b631cae9239deb1ef0","会社名":"久光製薬(株)【4530】","証券コード":"4530","決算期":"2014年2月期","会計方式":"日本方式","決算発表日":"2014年4月10日","決算月数":"12か月","売上高":"150,635百万円","営業利益":"19,123百万円","経常利益":"28,910百万円","当期利益":"21,357百万円","EPS（一株当たり利益）":"249.30円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,281.40円","総資産":"251,852百万円","自己資本":"195,443百万円","資本金":"8,473百万円","有利子負債":"2,529百万円","自己資本比率":"77.6%","ROA（総資産利益率）":"9.17%","ROE（自己資本利益率）":"11.78%","総資産経常利益率":"12.41%","__v":0,"日付":"2015-04-04T06:50:30.667Z"},{"_id":"551f89b631cae9239deb1ef1","会社名":"久光製薬(株)【4530】","証券コード":"4530","決算期":"2013年2月期","会計方式":"日本方式","決算発表日":"2013年4月11日","決算月数":"12か月","売上高":"142,772百万円","営業利益":"25,326百万円","経常利益":"33,051百万円","当期利益":"18,809百万円","EPS（一株当たり利益）":"219.56円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,951.54円","総資産":"214,141百万円","自己資本":"167,186百万円","資本金":"8,473百万円","有利子負債":"2,663百万円","自己資本比率":"78.1%","ROA（総資産利益率）":"9.24%","ROE（自己資本利益率）":"11.93%","総資産経常利益率":"16.24%","__v":0,"日付":"2015-04-04T06:50:30.668Z"},{"_id":"551f89b631cae9239deb1ef2","会社名":"久光製薬(株)【4530】","証券コード":"4530","決算期":"2012年2月期","会計方式":"日本方式","決算発表日":"2012年4月10日","決算月数":"12か月","売上高":"137,794百万円","営業利益":"25,937百万円","経常利益":"33,494百万円","当期利益":"18,439百万円","EPS（一株当たり利益）":"215.09円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,730.22円","総資産":"192,838百万円","自己資本":"148,227百万円","資本金":"8,473百万円","有利子負債":"5,669百万円","自己資本比率":"76.9%","ROA（総資産利益率）":"9.51%","ROE（自己資本利益率）":"12.78%","総資産経常利益率":"17.28%","__v":0,"日付":"2015-04-04T06:50:30.668Z"},{"_id":"55200a43b6241657bb27118b","会社名":"久光製薬(株)【4530】","証券コード":"4530","決算期":"2014年2月期","会計方式":"日本方式","決算発表日":"2014年4月10日","決算月数":"12か月","売上高":"150,635百万円","営業利益":"19,123百万円","経常利益":"28,910百万円","当期利益":"21,357百万円","EPS（一株当たり利益）":"249.30円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,281.40円","総資産":"251,852百万円","自己資本":"195,443百万円","資本金":"8,473百万円","有利子負債":"2,529百万円","自己資本比率":"77.6%","ROA（総資産利益率）":"9.17%","ROE（自己資本利益率）":"11.78%","総資産経常利益率":"12.41%","__v":0,"日付":"2015-04-04T15:58:59.291Z"}]